PSYC Continues to Bolster Leadership Team with Key Sales & Branding Advisory Board Appointments

LAKE OSWEGO, OR, Jan. 10, 2022 (GLOBE NEWSWIRE) -- Global Trac Solutions, Inc. (OTCPink: PSYC) (“Global” “PSYC” or the “Company”) a media leader for the emerging sector of medicinal psychedelics, and authorities behind Psychedelic Spotlight, a top ranking psychedelic news and information platform, is pleased to announce that as the Company continues to devote considerable focus towards strengthening its core leadership team, it is proud to welcome Mitchell J. Schlesinger and Sarah Abelsohn to the growing PSYC Advisory Board as key sales and branding expert additions.

Combined with the recent additions of Christopher Bitonti and Craig Schlesinger, the Company believes it is effectively rounding out the PSYC Advisory Board with passionate professionals who can contribute a wealth of vital knowledge and expertise to the Company and its growing Psychedelic Spotlight team across the fields of business operations, financial management, marketing, sales, and branding. 

With more than 30 years of experience in creative advertising, strategic marketing, and branding, which includes working for global brands including Avis Rent-A-Car, Norwegian Cruises, Costa Cruises, and Marco Polo Cruises, the Company will look to Mr. Schlesinger for guidance and leadership with strategic brand messaging and developing and implementing sales and marketing Key Performance Indicators (“K.P.I.’s”) for its Psychedelic Spotlight media platform in addition to refining PSYC’s evolving image within the public market sector. 

“I spent my career building brands with unique product positionings and innovating them by designing strategic brand implementation programming,” said Mr. Schlesinger. “The emerging psychedelic sector is especially unique on several fronts and the cutting edge of revolutionary medicinal therapies. I look forward to working with the PSYC team to innovate, monetize, and solidify the Company’s position as the sector’s dominant news, multimedia, and business platform for both consumers and business partners. It’s an exciting time to join PSYC’s dynamic team.”

Ms. Abelsohn, meanwhile, will transition into her role as an Advisor for PSYC after serving as the Director of Psychedelic Spotlight since early 2021. She initially joined the Psychedelic Spotlight team in June 2020 as a sales and marketing consultant and played an integral role over the past year-and-a-half with developing the dynamic, industry leading, visual brand aesthetic that is now associated with Psychedelic Spotlight. 

“It gives me great pride to be joining the PSYC advisory board,” said Ms. Abelsohn. “I am excited to continue lending my insight and support to the team and to help impact the growth of our ever-expanding audience for Psychedelic Spotlight. I believe there is so much in store for this talented team, I'm humbled at the opportunity to be an Advisor, and excited for what's to come.”

“Surrounding the Psychedelic Spotlight team and myself with highly-skilled individuals who are inspired and passionate about what we are building here at PSYC provides us with, what I think, is a very unique competitive advantage in terms of our ability to continue executing on our fundamental growth and monetization-focused initiatives throughout 2022 and beyond,” said PSYC CEO, David Flores. “A critical part of our existing monetization initiatives, in my opinion, are tied directly to our ability to develop and deploy effective sales, marketing, and branding initiatives. For this reason, I am confident that the additions of Mr. Schlesinger and Ms. Abelsohn to the PSYC Advisory Board will prove extremely beneficial for PSYC based on the dynamic expertise, knowledge, and passion they will each be able to contribute at this pivotal time in our Company’s growth.” 

About Global Trac Solutions, Inc. (OTCPink: PSYC)

At Global Trac Solutions we are integrating media, creativity, and technology to develop and deploy thought-provoking ideas and solutions that are fostering and transforming the approach to some of society’s most pressing matters.

PSYC has expressed its intent and commitment to positioning itself at the forefront of the psychedelic revolution and as a resource center for discovering and understanding the latest research and business opportunities surrounding psychedelic inspired medicines. In conjunction with the FDA’s more open-minded approach to psychedelic medicines, and as several major U.S. cities continue to approve the decriminalization of psilocybin, we believe investors are speculating that the psychedelic boom could be bigger than that of cannabis. PSYC is your source for current investment related news specific to psychedelic medicines and cutting-edge research improving overall health, moving this sector into the mainstream.

We are dedicated to a forward-thinking approach that embraces groundbreaking new technology and innovations and through the vision of business development we intend to continue to evolve into these unchartered territories as the industry leaders of the future.

Forward-Looking Statements Disclaimer:

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In some cases, you can identify forward-looking statements by the following words: "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "ongoing," "plan," "potential," "predict," "project," "should," "will," "would," or the negative of these terms or other comparable terminology, although not all forward-looking statements contain these words. Forward-looking statements are not a guarantee of future performance or results and will not necessarily be accurate indications of the times at, or by, which such performance or results will be achieved. Forward-looking statements are based on information available at the time the statements are made and involve known and unknown risks, uncertainty and other factors, including the effect of COVID-19 and the success of the current vaccine distribution, the adverse effect of the Omicron variant, that may cause our results, levels of activity, performance or achievements to be materially different from the information expressed or implied by the forward-looking statements in this press release. This press release should be considered in light of all filings of the Company that are disclosed on the OTC Markets.com website and is not incorporated by reference into such reports.

Disclaimer: Global Trac Solutions, Inc. does not in any way encourage or condone the use, purchase, sale or transfer of any illegal substances, nor do we encourage or condone partaking in any unlawful activities. We support a harm reduction approach for the purpose of education and promoting individual and public safety. If you are choosing to use psychedelic substances, please do so responsibly.

Corporate Contact:
Global Trac Solutions, Inc. (PSYC)
www.globaltracsolutions.com
(702) 239-1919
[email protected]
OTCPINK: PSYC